首页> 外文期刊>Food analytical methods >Comparative Assessment of Trypsin Inhibitor vis-A -vis Kunitz Trypsin Inhibitor and Bowman-Birk Inhibitor Activities in Soybean
【24h】

Comparative Assessment of Trypsin Inhibitor vis-A -vis Kunitz Trypsin Inhibitor and Bowman-Birk Inhibitor Activities in Soybean

机译:胰蛋白酶抑制剂Vis-A-VIS Kunitz胰蛋白酶抑制剂和Bowman-Birk抑制剂活性的比较评估

获取原文
获取原文并翻译 | 示例
           

摘要

Trypsin inhibitor activity (TIA) in soybean is attributed to two polypeptides, namely, Kunitz trypsin inhibitor (KTI) and Bowman-Birk inhibitor (BBI). Standard spectrophotometric protocol widely followed for estimation of TIA is cumbersome and does not distinguish KTI from BBI. In the present investigation, extraction conditions for KTI were optimized and different forms of this polypeptide were resolved in 180 soybean genotypes of Indian and exotic origin through native PAGE. This led to the identification of three KTI alleles, namely, Ti (a) , Ti (b) , and Ti (c) , with Ti (a) occurring in most of the Indian genotypes. Trypsin-KTI complex assay exhibited binding of Ti (a) polypeptide with 2.51 fold concentration of trypsin. Subsequently, seeds of selected genotypes were subjected to estimation of KTI and BBI activity through densitometry and enzyme-linked immunosorbent assay (ELISA), respectively; and total TIA through standard spectrophotometric protocol. Summation of KTI and BBI was significantly (P & 0.05) lower than that of TIA determined through the spectrophotometric method.
机译:胰蛋白酶抑制剂活性(TIA)在大肽中归因于两种多肽,即Kunitz胰蛋白酶抑制剂(KTI)和Bowman-Birk抑制剂(BBI)。广泛遵循的标准分光光度法,估计TIA是麻烦的,并且不区分KTI从BBI。在本研究中,通过天然页面优化了KTI的提取条件,并通过天然页面在印度和异国情调起源的180个大豆基因型中解决了不同形式的该多肽。这导致鉴定三个KTI等位基因,即Ti(A),Ti(B)和​​Ti(C),其中Ti(a)发生在大多数印度基因型中。胰蛋白酶-KTI复杂测定表现出Ti(a)多肽的结合,胰蛋白酶的胰蛋白酶浓度为2.51倍。随后,通过密度测定法和酶联免疫吸附测定(ELISA)进行所选基因型的种子估计KTI和BBI活性;通过标准分光光度法协议和总TIA。 KTI和BBI的总和显着(P& 0.05)低于通过分光光度法确定的TIA的求和。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号